Register For Module 1 | Free-To-Attend
Module 1 of this course is free to attend and delivered online. Register to receive joining instructions for the live event, recording and presentation slides.
£1,395.00 Original price was: £1,395.00.£995.00Current price is: £995.00.
The price is for all four sessions | Register for Module 1 | Free
Master the scientific, regulatory, and strategic complexities of cell therapy development to accelerate progress from bench to bedside
Module 1 of this course is free to attend and delivered online. Register to receive joining instructions for the live event, recording and presentation slides.
Discount has been applied to the price above. VAT, if applicable, will be added.
Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.
The field of cell therapy holds transformative potential for treating a wide range of diseases. However, it also presents unique and complex challenges that can hinder the development and commercialisation of these innovative therapies. The course Mastering Development and Regulatory Challenges in Cell Therapy is designed to equip biotech and pharmaceutical professionals with the in-depth knowledge and strategic insights needed to navigate the complexities of developing cell-based therapies.
By the end of this course, participants will have gained a comprehensive understanding of cell therapy and how to address the key challenges in developing cell-based therapeutics. They will be equipped to make strategic decisions that improve the probability of success, reduce risks, and support the effective development of complex cell therapy approaches.
Find out when this course is running so you can plan your training. Scroll down to view the full agenda.
4-Day Live Online Training
Register at the top of the page.
4-Day Live Online Training
Register at the top of the page.
If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.
For a quote, complete our contact form by following the link. Get in touch.
We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.
For more information, complete our contact form by following the link. Get in touch.
Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)
Pre-course
Action Plan
Reinforcement Session
Sign up
7 January 2026 | 60 mins | 1:00 PM UK
Introduction to Cell Therapy Development
There are limited spaces on module 1. If demand is high you may not be able to attend the live session, however you will be sent the recording. Priority is given to full registrations.
9 February 2026 | 180 mins | 1:00 PM UK
Introduction to Cell Therapy Development
Pharmacology Challenges in Cell Therapy
10 February 2026 | 180 mins | 1:00 PM UK
Preclinical to Clinical Translation
CMC and Scale-Up Challenges
11 February 2026 | 180 mins | 1:00 PM UK
Regulatory Considerations for Cell Therapies
Leveraging Differentiation and Competitive Intelligence
12 February 2026 | 180 mins | 1:00 PM UK
Strategic Insights for Successful Development
Case Studies and Emerging Trends
Gareth is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).
In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.
Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.
This course is designed for professionals involved in the development, manufacturing, and regulation of cell-based therapies, including those in R&D, clinical development, regulatory affairs, quality assurance, manufacturing, and business development within small biotech and large pharmaceuticals.
It is also beneficial for senior executives who want to improve their understanding of the development process to improve commercial decision-making.
Reviews
There are no reviews yet.